Envoy Medical, Inc. (COCH) vs DarioHealth Corp. (DRIO)
A side-by-side comparison of Envoy Medical, Inc. and DarioHealth Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COCH
Envoy Medical, Inc.
$0.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
DRIO
DarioHealth Corp.
$6.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — COCH vs DRIO
growth of $100 · dividends reinvested · last 5yCOCH -93.3% (-41.8%/yr)DRIO -98.7% (-57.8%/yr)COCH compounded faster over this window
Log scale — wide-divergence pair
COCH DRIO
COCH vs DRIO: by the numbers
- •COCH is the larger company ($50M vs $44M market cap).
- •DRIO is profitable (322.77% net margin) while COCH runs a net loss (-11304.83%).
Metrics side by side
Valuation
| Metric | COCH | DRIO |
|---|---|---|
| P/E ratio | N/A | 8.72 |
| P/S ratio | 242.85 | 2.10 |
| P/B ratio | 15.22 | 0.80 |
Profitability
| Metric | COCH | DRIO |
|---|---|---|
| Gross margin | -262.66% | 56.09% |
| Operating margin | -9240.66% | -163.94% |
| Net margin | -11304.83% | 322.77% |
| ROE | -708.48% | 123.04% |
| ROIC | -208.76% | -78.42% |
Growth (annualized)
| Metric | COCH | DRIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.10% |
| Total return CAGR (5Y) | -41.73% | -52.92% |
Frequently asked
- Is COCH or DRIO more profitable?
- DRIO runs the higher net margin — COCH at -11304.83% versus DRIO at 322.77%.
- How have COCH and DRIO total returns compared?
- Over the past 5 years, COCH delivered -41.73% and DRIO delivered -52.92% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DarioHealth P/E ratioEnvoy Medical ROEDarioHealth ROEEnvoy Medical operating marginDarioHealth operating marginEnvoy Medical revenue growthDarioHealth revenue growthEnvoy Medical free cash flowDarioHealth free cash flow
Envoy Medical & DarioHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.